Late-stage cancer diagnoses lead to higher treatment costs and reduced chances of successful recovery. Existing cancer screening programs may not be easily accessible or tailored to individual risk profiles, hindering early detection efforts.

Onco Connect offers AI-powered cancer risk assessment and personalized screening programs designed to improve early cancer detection. The platform uses advanced algorithms to analyze individual risk factors and recommend appropriate screening protocols for prevalent cancers. By partnering with employers, insurers, healthcare providers, and government programs, Onco Connect aims to make proactive cancer care more accessible and affordable. The solution facilitates early diagnosis and treatment, ultimately improving patient outcomes and reducing the overall burden of cancer.

AI-led cancer risk assessment for prevalent cancers

Tailored screening programs for organizations and government initiatives

Access to expert cancer opinions from specialists in India, UK, and Singapore

Structured framework to support employers in improving employee health and retention

Solutions for insurers to enhance underwriting and promote corporate wellness

Tools for healthcare providers to assist in early detection, diagnosis, and treatment

Support for government programs to promote early detection and affordable cancer care

Onco Connect primarily serves employers, insurers, healthcare providers, and government programs seeking to improve cancer detection rates and reduce the costs associated with late-stage diagnoses.